Approved in EU

Defitelio®▼ (defibrotide) is licensed in the European Union for the treatment of severe hepatic veno-occlusive disease (VOD) in patients over one month of age undergoing hematopoietic stem cell transplantation therapy.

Click here for additional product information.


▼This medicine is under additional monitoring.

General News

Financial News

Contact Us

In focus

Gentium S.p.A. is a
Jazz Pharmaceuticals company.

To learn more about Jazz Pharmaceuticals, click here

Gentium S.p.A. - P.IVA n. 02098100130